Treatment of Proximal Humerus Fractures in the Elderly (prox_hum)

February 22, 2022 updated by: University Hospital, Basel, Switzerland

Treatment Options for Proximal Humerus Fractures in the Elderly and Their Implication on Personal Independence

This study is set to evaluate a proposed standard for the treatment of proximal humerus fractures

Study Overview

Status

Completed

Conditions

Detailed Description

This study investigates the effect of routine treatment algorithm for proximal humerus fractures. All applied treatments are approved and reflect routine practice. The follow-up investigation as planned for this study is associated with only minimal risk for the concerned patients.

Study Type

Observational

Enrollment (Actual)

160

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Basel-Stadt
      • Basel, Basel-Stadt, Switzerland, 4021
        • University Hospital Basel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients fulfilling all of the following inclusion criteria

Description

Inclusion Criteria:

  • Age of 65 years or above
  • Proximal humerus fracture
  • Informed consent by the patient or legal representatives to participate in the study

Exclusion Criteria:

  • More than one fracture, polytrauma
  • Suspicion of a pathological fracture in the context of known or unknown malignancy
  • Previous surgery of the proximal humerus on the same side
  • High energy trauma
  • Open Fracture
  • Insufficient German language skills

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
experimental intervention
A greater degree of initial displacement is tolerated to allow for conservative, non-operative treatment in more simple fracture patterns. Two-part fractures with marked displacement including two part patterns with a non-displaced greater or minor tuberosity fracture (formally three part fractures) are treated with a proximal humerus nail; and displaced three and four part fractures are primarily managed with a reverse total shoulder arthroplasty. Proximal Humeral Internal Locking System (PHILOS)-plates are only used exceptionally in this group of patients.
The new treatment algorithm was applied to all patients with proximal humerus fracture as from May 2013 onwards
control intervention

Since May 2013 we have changed our treatment algorithm for the treatment of fractures of the humeral head in the elderly. Before this change in algorithm we used PHILOS plates extensively and rarely Inverse Shoulder prostheses.

In general all proximal humerus fractures were operated except minimally or undisplaced.

The old treatment algorithm was applied to all patients with proximal humerus fracture up to May 2013.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
personal dependency status
Time Frame: 6 months
A simple four point rating is used at the time of injury (for the premorbid state) and at 6 months to demonstrate the impact of the injury (including its treatment) on the ability to return to the former social environment and degree of self-dependency.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
range of motion
Time Frame: 6 months
6 months
Shoulder pain and disability index (SPADI)
Time Frame: 6 months
The SPADI is a patient-based questionnaire containing 15 questions about pain and activities of daily living that must be answered by the patient on a scale of 0-10 (0 = no pain / no difficulties to 10 = Worst pain / activity). Five questions relate to the pain and 8 questions relate to the function in daily activities, both subscores are combined and converted to the total score to 0 (= lowest score) to 100 (= best result). A validated German version is available
6 months
SSV
Time Frame: 6 months
The Subjective Shoulder Value (SSV) is based on a single question that is answered subjectively by the patients. The English formulation of this question is: "What is the overall percent value of your shoulder if a completely normal shoulder represents 100%?" 12 It is an easily administered measure of shoulder function.
6 months
General health using EuroQuality of life (EQ)-5D-5L visual analogue scale (VAS)
Time Frame: 6 months
The gain in quality of life within two years after surgery is assessed using the generic Quality of Life (QoL) EuroQoL EQ-5D-5L instrument.
6 months
Quality of life (utilities) derived using EQ-5D-5L
Time Frame: 6 months
Using the EQ-5D-5L instrument patients are asked to report on their general health status on a VAS scale from 0 (worst possible health) to 100 (best possible health).
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Daniel Rikli, Prof, University Hospital, Basel, Switzerland

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2015

Primary Completion (Actual)

December 31, 2019

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

September 30, 2015

First Submitted That Met QC Criteria

September 30, 2015

First Posted (Estimate)

October 1, 2015

Study Record Updates

Last Update Posted (Actual)

March 10, 2022

Last Update Submitted That Met QC Criteria

February 22, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • EKNZ 2014-310

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Humeral Fractures

Clinical Trials on treatment/medical device

3
Subscribe